The Cancer Immunotherapy Market is witnessing a remarkable surge, projected to reach approximately USD 125.93 billion by 2035, reflecting a compound annual growth rate (CAGR) of 4.99%. This growth trajectory is fueled by groundbreaking therapies that are gaining traction in the treatment landscape. Notably, the market was valued at USD 73.7 billion in 2024 and USD 77.38 billion in 2025,...